Diagnosis and Management of Tumor-induced Osteomalacia: Perspectives from Clinical Experience

Keyphrases

• Clinical Experience 100%
• Tumor-induced Osteomalacia 100%
• Fibroblast Growth Factor 23 (FGF23) 30%
• Tumor 20%
• Phosphate 20%
• Healthcare Professionals 10%
• Differential Diagnosis 10%
• Targeted Therapy 10%
• Serum Phosphorus 10%
• Diagnosis Treatment 10%
• 1,25-dihydroxyvitamin D3 10%
• Appropriate Treatment 10%
• Accurate Diagnosis 10%
• Functional Imaging 10%
• Curative Treatment 10%
• Clinical Presentation 10%
• Surgical Resection 10%
• Paraneoplastic Syndrome 10%
• Patient Management 10%
• Delayed Diagnosis 10%
• Medical Education 10%
• Collective Experience 10%
• Enhanced Awareness 10%
• Patient History 10%
• Vitamin D Metabolism 10%
• Endocrine Tumors 10%
• Debilitating Disease 10%
• Musculoskeletal Pain 10%
• Reabsorption 10%
• Anatomical Imaging 10%
• Medical Community 10%
• Non-specific Symptoms 10%
• Long-term Disability 10%
• Diagnostic Pathway 10%
• Dallas 10%
• Venous Sampling 10%
• Multiple Fractures 10%
• Proximal muscle Weakness 10%
• Laboratory Assessment 10%
• Treatment Pathways 10%

Medicine and Dentistry

• Oncogenic Osteomalacia 100%
• Fibroblast Growth Factor 23 30%
• Neoplasm 20%
• Awareness 20%
• Diagnosis 10%
• Differential Diagnosis 10%
• Targeted Therapy 10%
• Diagnostic Error 10%
• Laboratory Test 10%
• Muscle Weakness 10%
• Endocrine Tumor 10%
• Musculoskeletal Pain 10%
• Vitamin D Metabolism 10%
• Delayed Diagnosis 10%
• Paraneoplastic Syndrome 10%
• Multiple Fracture 10%
• Laboratory Assessment 10%
• Surgery 10%
• Diseases 10%